These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22321558)

  • 41. Epidermal growth factor receptor mutations are associated with gefitinib sensitivity in non-small cell lung cancer in Japanese.
    Uramoto H; Sugio K; Oyama T; Ono K; Sugaya M; Yoshimatsu T; Hanagiri T; Morita M; Yasumoto K
    Lung Cancer; 2006 Jan; 51(1):71-7. PubMed ID: 16198442
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of EGFR gene mutation in lung cancer by mutant-enriched polymerase chain reaction assay.
    Asano H; Toyooka S; Tokumo M; Ichimura K; Aoe K; Ito S; Tsukuda K; Ouchida M; Aoe M; Katayama H; Hiraki A; Sugi K; Kiura K; Date H; Shimizu N
    Clin Cancer Res; 2006 Jan; 12(1):43-8. PubMed ID: 16397022
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improvement in the quality of molecular analysis of EGFR in non-small-cell lung cancer detected by three rounds of external quality assessment.
    Deans ZC; Bilbe N; O'Sullivan B; Lazarou LP; de Castro DG; Parry S; Dodson A; Taniere P; Clark C; Butler R
    J Clin Pathol; 2013 Apr; 66(4):319-25. PubMed ID: 23378269
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The close correlation between 8-hydroxy-2'-deoxyguanosine and epidermal growth factor receptor activating mutation in non-small cell lung cancer.
    Kawahara A; Azuma K; Hattori S; Nakashima K; Basaki Y; Akiba J; Takamori S; Aizawa H; Yanagawa T; Izumi H; Kohno K; Kono S; Kage M; Kuwano M; Ono M
    Hum Pathol; 2010 Jul; 41(7):951-9. PubMed ID: 20236686
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epidermal growth factor receptor mutation in lung cancer are linked to bronchioloalveolar differentiation.
    Blons H; Côté JF; Le Corre D; Riquet M; Fabre-Guilevin E; Laurent-Puig P; Danel C
    Am J Surg Pathol; 2006 Oct; 30(10):1309-15. PubMed ID: 17001163
    [TBL] [Abstract][Full Text] [Related]  

  • 46. EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.
    Bae NC; Chae MH; Lee MH; Kim KM; Lee EB; Kim CH; Park TI; Han SB; Jheon S; Jung TH; Park JY
    Cancer Genet Cytogenet; 2007 Mar; 173(2):107-13. PubMed ID: 17321325
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Young male with fanconi anemia and EGFR-mutant non-small-cell lung cancer.
    Cathcart-Rake E; Lopez-Chavez A
    J Thorac Oncol; 2014 Nov; 9(11):e83-5. PubMed ID: 25436812
    [No Abstract]   [Full Text] [Related]  

  • 48. Epidermal growth factor receptor mutation status in cell-free DNA supernatant of bronchial washings and brushings.
    Kawahara A; Fukumitsu C; Taira T; Abe H; Takase Y; Murata K; Yamaguchi T; Azuma K; Ishii H; Takamori S; Akiba J; Hoshino T; Kage M
    Cancer Cytopathol; 2015 Oct; 123(10):620-8. PubMed ID: 26235264
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel method for detection of mutation in epidermal growth factor receptor.
    Zhao J; Zhao J; Huang J; Chen Y; Jiang J; Wu W; Wang P; Liu L; Li L; Wu L; Wang M; Chen W
    Lung Cancer; 2011 Nov; 74(2):226-32. PubMed ID: 21439672
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A blood-based test for epidermal growth factor receptor mutations in lung cancer.
    Bell DW; Haber DA
    Clin Cancer Res; 2006 Jul; 12(13):3875-7. PubMed ID: 16818680
    [No Abstract]   [Full Text] [Related]  

  • 51. Transbronchial fine-needle aspiration, epidermal growth factor receptor mutations, and the scorpion's touch.
    Zander DS
    Chest; 2007 Jun; 131(6):1619-20. PubMed ID: 17565010
    [No Abstract]   [Full Text] [Related]  

  • 52. Molecular signatures of lung cancer--toward personalized therapy.
    Herbst RS; Lippman SM
    N Engl J Med; 2007 Jan; 356(1):76-8. PubMed ID: 17202459
    [No Abstract]   [Full Text] [Related]  

  • 53. Epidermal growth factor receptor overexpression: the importance of context.
    Carbone DP
    J Clin Oncol; 2003 Dec; 21(23):4268-9. PubMed ID: 14581439
    [No Abstract]   [Full Text] [Related]  

  • 54. [Analysis of mutation feature at exon 19 of epidermal growth factor receptor gene in non-small cell lung cancer from Chinese patients].
    Wang HY; Luo H; Zhao YM; Tang L; Yi XH; Zhou CC
    Zhonghua Bing Li Xue Za Zhi; 2008 Jun; 37(6):405-6. PubMed ID: 19031721
    [No Abstract]   [Full Text] [Related]  

  • 55. Multigene mutation analysis on cytologic samples.
    Fleury-Feith J; Gounant V; Lacave R; Cadranel J; Bernaudin JF
    Chest; 2011 Dec; 140(6):1664. PubMed ID: 22147827
    [No Abstract]   [Full Text] [Related]  

  • 56. Emerging gene mutation targets in lung cancer.
    Johnson BE
    Clin Adv Hematol Oncol; 2015 Dec; 13(12):812-4. PubMed ID: 27058846
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical Application of Liquid Biopsies.
    Williams PM; Conley BA
    JAMA Oncol; 2016 Aug; 2(8):1003-5. PubMed ID: 27054513
    [No Abstract]   [Full Text] [Related]  

  • 58. Prevalence of mutation in the epidermal growth factor receptor gene in Chinese patients with non-small cell lung cancer.
    Jiang B; Zhu ZZ; Liu F; Hou LF; Gu J; Chen E; Tzeng CM; Zhu G
    Clin Oncol (R Coll Radiol); 2006 Oct; 18(8):635. PubMed ID: 17051955
    [No Abstract]   [Full Text] [Related]  

  • 59. Squamous cell carcinoma of the lung: pattern of epidermal growth factor receptor mutation distribution in different populations: a summary.
    Wiwanitkit V
    Lung; 2006; 184(5):301-2. PubMed ID: 17235731
    [No Abstract]   [Full Text] [Related]  

  • 60. Biologic staging of non-small-cell lung cancer: prospect or proposal?
    Barlesi F; Jacot W; Pujol JL
    Clin Lung Cancer; 2005 Jan; 6(4):225-6. PubMed ID: 15694014
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.